C-MER MEDICAL (03309) announced on September 7 that it invested HK$70,000 to repurchase 80,000 shares.
Hema Medical (03309) announced that on September 7, 2026, it spent HKD 70,000 to repurchase 80,000 shares.
C-MER MEDICAL (03309) announced that it will repurchase 80,000 shares at a cost of HKD 70,000 on September 7, 2026.
Related Articles
NAYUKI (02150) spent HKD 1.504 million to repurchase 2.24 million shares on September 7.
XIAO NOODLES (02408) repurchased 113,500 shares at a cost of HKD 484,400 on September 7.
Shenzhen VMAX New Energy (688612.SH) plans to launch a restricted stock incentive plan in 2026.
NAYUKI (02150) spent HKD 1.504 million to repurchase 2.24 million shares on September 7.
XIAO NOODLES (02408) repurchased 113,500 shares at a cost of HKD 484,400 on September 7.
Shenzhen VMAX New Energy (688612.SH) plans to launch a restricted stock incentive plan in 2026.
RECOMMEND
